Ordinance
on Clinical Trials
with the exception of
Clinical Trials of Medical Devices1
(Clinical Trials Ordinance, ClinO)

of 20 September 2013 (Status as of 26 May 2022)

1 Amended by Annex 2 No 2 of the O of 1 July 2020 on Clinical Trials with Medical Devices, in force since 26 May 2021 (AS 2020 3033).


Open article in different language:  DE  |  FR  |  IT
Art. 57

1 For no­ti­fic­a­tions and re­port­ing in the case of clin­ic­al tri­als of trans­plant­a­tion, Art­icles 37–41, 43 and 44 ap­ply mu­tatis mutandis.45

2 The ob­lig­a­tions which must be ful­filled un­der these pro­vi­sions vis-à-vis the Agency are to be ful­filled, for clin­ic­al tri­als of trans­plant­a­tion, vis-à-vis the FOPH.

3 For clin­ic­al tri­als of trans­plant­a­tion, the du­ties of the spon­sor and the in­vest­ig­at­or con­cern­ing doc­u­ment­a­tion, trace­ab­il­ity and re­ten­tion of re­cords are gov­erned by Art­icles 34 and 35 of the Trans­plant­a­tion Act.

45 Cor­rec­tion of 27 Dec. 2013 (AS 2013 5579).

Previous article Show article in the law Next article

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Gesetzeskürzel Name
DE FR IT EN
DE FR IT EN
Laden